Knavel EM, Brace CL
Amylin vs GIP/GLP-1 dual agonists (tirzepatide) Tirzepatide (Mounjaro/Zepbound): Dual GIP + GLP-1 receptor agonist Single molecule, two pathways 15-22% weight loss monotherapy FDA approved Superior to semaglutide alone Tirzepatide vs cagrilintide monotherapy: Theoretical tirzepatide + cagrilintide combination: Would add amylin pathway to GIP/GLP-1 Three pathways total Potential 20-30% weight loss But no clinical data (unstudied) Very high GI side effect risk CagriSema (sema + cagri) safer, proven choice See our cagrilintide dosage with tirzepatide analysis
Jojoba oil closely resembles the skin's natural sebum, making it an ideal choice for all skin types, including oily and sensitive skin
Serving patients across Mumbai, Bandra, Khar, Andheri, Powai, Juhu, South Mumbai and international patients travelling to India for medically supervised peptide therapy .
Move regularly to support metabolism While GLP-1 medications can drive weight loss on their own, combining them with movement and lifestyle support leads to more sustainable results and better health markers